NCT05443464View on ClinicalTrials.gov

Mesenchymal Stem Cells (MSCs) for Steroid Refractory Acute GVHD (SR-aGVHD)

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 5, 2023

Primary Completion Date

June 10, 2024

Study Completion Date

October 14, 2024

Conditions
GVHD,Acute
Interventions
BIOLOGICAL

OSSM-001

Direct IV infusion of OSSM-001

Sponsors
All Listed Sponsors
lead

Ossium Health, Inc.

INDUSTRY

NCT05443464 - Mesenchymal Stem Cells (MSCs) for Steroid Refractory Acute GVHD (SR-aGVHD) | Biotech Hunter | Biotech Hunter